1. Others
  2. Others
  3. Dexrazoxane hydrochloride

Dexrazoxane hydrochloride  (Synonyms: 右雷佐生盐酸盐; ICRF-187 hydrochloride; ADR-529 hydrochloride; NSC-169780 hydrochloride)

目录号: HY-76201 纯度: 99.83%
COA 产品使用指南

Dexrazoxane hydrochloride (ICRF-187 hydrochloride) 是心脏保护剂,能够保持卵巢功能和生育能力。Dexrazoxane hydrochloride 具有抗氧化和抗炎作用,能够透过血脑屏障,改善运动功能障碍并具有神经保护作用,可用于神经退行性疾病研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Dexrazoxane hydrochloride Chemical Structure

Dexrazoxane hydrochloride Chemical Structure

CAS No. : 149003-01-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
5 mg ¥312
In-stock
10 mg ¥500
In-stock
50 mg ¥980
In-stock
100 mg ¥1350
In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Dexrazoxane hydrochloride:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Dexrazoxane hydrochloride (ICRF-187 hydrochloride) is a heart protectant that can help preserve ovarian function and fertility. Dexrazoxane hydrochloride has antioxidant and anti-inflammatory properties, can cross the blood-brain barrier, improves motor function disorders, and offers neuroprotective effects, making it useful in the study of neurodegenerative diseases[1][2][3][4].

IC50 & Target

As a derivative of EDTA, dexrazoxane chelates iron, thus reduce the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals. This agent is used to protect the heart against the cardiotoxic side effects of anthracyclines, such as doxorubicin. It was speculated that dexrazoxane could be used for further investigation to synthesize new antimalarial drugs.

体外研究
(In Vitro)

Dexrazoxane (0-500 μM; 0-24 h) 在人纤维肉瘤细胞中诱导 DNA 断裂、ATF3 累积、DNA 损伤反应和凋亡[1]
Dexrazoxane hydrochloride 保护卵巢细胞免受 DXR 诱导的 DNA 损伤 (中性彗星分析)[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: Topoisomerase IIα-expressing HTETOP cells (HTETOP cells were derived from the human fibrosarcoma cell line HT1080 through the deletion of both endogenous topoisomerase IIα alleles and the insertion of a tetracycline-repressible topoisomerase IIα transgene)
Concentration: 100 μM
Incubation Time: 4 h
Result: Increased the phosphorylation level of Chk1, Chk2, ATR, and ATM.

Western Blot Analysis[1]

Cell Line: HTETOP cells
Concentration: 0, 10, 100 and 500 μM
Incubation Time: 0, 1, 4, 8 and 24 h
Result: Increased AFT3 protein levels in a concentration-dependent and incubation time-dependent manner.

Western Blot Analysis[1]

Cell Line: Topoisomerase IIα-expressing HTETOP cells
Concentration: 100 μM
Incubation Time: 24 h
Result: Increased the expression level of P53.
体内研究
(In Vivo)

Dexrazoxane hydrochloride (20 mg/kg,腹腔注射,单次剂量) 减轻小鼠 DXR (HY-121259) 化疗急性卵巢毒性,提高长期生育能力[2]
Dexrazoxane hydrochloride (0-120 mg/kg,静脉注射,一周一次,13 周) 在大鼠、小鼠和狗中剂量依赖性的降低 DOX 引起的心脏毒性,但在较高剂量的 DOX 下,效果较差[3]
Dexrazoxane hydrochloride (1.5-15 mg/kg,腹腔注射,单次剂量) 改善小鼠运动功能障碍,保护多巴胺能神经元免受神经毒素诱导的 SNc 变性,并伴有神经胶质细胞活化减弱,抑制氧化应激和内质网应激[4]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: CD-1 mice induced by DXR[2]
Dosage: 20 mg/kg, single dose
Administration: Intraperitoneal injection (i.p.)
Result: Reduced the degree of DNA double-strand breaks, reduced the activation of γ-h2fax, reduced follicular cell death, reduced the infertility index, and improved fertility.
Animal Model: ICR Swiss mouse, Sprague Dawley rat, Beagle dog induce by DOX[3]
Dosage: 0, 10, 20, 40, 80, 120 mg/kg (10 times DOX in 7 weeks); 4, 8, 16 mg/kg (once a week DOX, 13 weeks); 2, 6, 16 mg/kg (once a week DOX, 13 weeks)
Administration: Intravenous injection (i.v.)
Result: Deduced MTS in mice at different dose ratios, but the effect was less effective for higher doses of DOX. In rats, MTS was reduced in both sexes, but cardiac damage was still evident in male rats that received the highest dose of DOX. MTS decreased significantly in both sexes but cardiac lesions were still observed in dogs in all treatment groups.
Animal Model: Rat induced by 6-OHDA (HY-B1081A)[4]
Dosage: 1.5, 5, 10, 15 mg/kg; single dose
Administration: Intraperitoneal injection (i.p.)
Result: Improved contralateral rotation behavior, inhibited the activation of microglia in the SNc, reversed the ratio of the injured side to the intact side in the number of TH+ immunoreactive neurons, inhibited TNF-α and IL-1β content, abolished MDA formation, and reduced the changes in GSHPX and SOD.
Clinical Trial
分子量

341.19

Formula

C11H18Cl2N4O4

CAS 号
性状

固体

颜色

White to off-white

中文名称

右雷佐生盐酸盐;右丙亚胺盐酸盐

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据
细胞实验: 

DMSO 中的溶解度 : 50 mg/mL (146.55 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

H2O 中的溶解度 : 20 mg/mL (58.62 mM; 超声助溶)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.9309 mL 14.6546 mL 29.3092 mL
5 mM 0.5862 mL 2.9309 mL 5.8618 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验:

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 3 mg/mL (8.79 mM); 澄清溶液

    此方案可获得 ≥ 3 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 30.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

    生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
  • 方案 二

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 3 mg/mL (8.79 mM); 澄清溶液

    此方案可获得 ≥ 3 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 30.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

    2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。

以下溶解方案,请直接配制工作液。建议现用现配,在短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比; 如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。

  • 方案 一

    请依序添加每种溶剂: PBS

    Solubility: 130 mg/mL (381.02 mM); 澄清溶液; 超声助溶

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
该产品水溶性佳,请具体参考实测 水 / PBS / Saline 中的溶解度数据。
您所需的储备液浓度超过该产品的实测溶解度,如有需要,请与 MCE 中国技术支持联系。
纯度 & 产品资料

纯度: 99.83%

参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
H2O / DMSO 1 mM 2.9309 mL 14.6546 mL 29.3092 mL 73.2730 mL
5 mM 0.5862 mL 2.9309 mL 5.8618 mL 14.6546 mL
10 mM 0.2931 mL 1.4655 mL 2.9309 mL 7.3273 mL
15 mM 0.1954 mL 0.9770 mL 1.9539 mL 4.8849 mL
20 mM 0.1465 mL 0.7327 mL 1.4655 mL 3.6636 mL
25 mM 0.1172 mL 0.5862 mL 1.1724 mL 2.9309 mL
30 mM 0.0977 mL 0.4885 mL 0.9770 mL 2.4424 mL
40 mM 0.0733 mL 0.3664 mL 0.7327 mL 1.8318 mL
50 mM 0.0586 mL 0.2931 mL 0.5862 mL 1.4655 mL
DMSO 60 mM 0.0488 mL 0.2442 mL 0.4885 mL 1.2212 mL
80 mM 0.0366 mL 0.1832 mL 0.3664 mL 0.9159 mL
100 mM 0.0293 mL 0.1465 mL 0.2931 mL 0.7327 mL

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Dexrazoxane hydrochloride
目录号:
HY-76201
需求量: